Trial of Methylphenidate and Thioridazine
A double-blind, placebo-controlled, cross-over study of methylphenidate (0.4 mg/kg/day) and thioridazine (1.75 mg/kg/day) in 27 intellectually subaverage children is reported from The Nisonger Center for Mental Retardation and Developmental Disabilities, Ohio State Univ., Columbus, OH, and the Unive...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pediatric Neurology Briefs Publishers
1991-09-01
|
| Series: | Pediatric Neurology Briefs |
| Subjects: | |
| Online Access: | https://www.pediatricneurologybriefs.com/articles/3251 |